Skip Navigation LinksHome > September 2011 - Volume 26 - Issue > An open label, multicenter, single arm, 4-week study to eval...
International Clinical Psychopharmacology:
doi: 10.1097/01.yic.0000405669.70275.95
The 11th International Review of Bipolar Disorders, 4-6 April 2011, Rome, Italy: Oral Platform Presentations

An open label, multicenter, single arm, 4-week study to evaluate the efficacy and safety of flexible dose of quetiapine fumarate (Seroquel) switching from other drugs in the treatment of acute manic patients with bipolar disorder

Li, Jie; Jia, YanBin; Chen, XiaoDong; Gong, MeiEn; Zhang, HongWei

Login